UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003519
Receipt number R000003782
Scientific Title Genetic study of autoimmune pancreatitis and IgG4-related diseases.
Date of disclosure of the study information 2010/04/22
Last modified on 2016/04/23 19:40:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Genetic study of autoimmune pancreatitis and IgG4-related diseases.

Acronym

Genetic study of AIP

Scientific Title

Genetic study of autoimmune pancreatitis and IgG4-related diseases.

Scientific Title:Acronym

Genetic study of AIP

Region

Japan


Condition

Condition

IgG4 related disease, autoimmune pnacreatitis, and the cases with differential diagnosis to IgG4-related diseases (chronic pancreatitis (alcohol, idiopathic etc), Sjogren's syndrome, primary sclerosing cholangitis, interstitial nephritis, interstitial pneuminia, retoroperitoneal fibrosis, pseudo tumor, etc)

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To identyfy specific genes associated with autoimmune pancreatitis and IgG4-related diseases.

Basic objectives2

Others

Basic objectives -Others

To apply the genomic information to diagnosis and treatment of AIP and IgG4-related diseases.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

GWAS, epigenetics

Key secondary outcomes

Clinical data of AIP and IgG4-related diseases.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

blood sampling

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

The patients with AIP diagnosed according to Asian criteria for AIP or suspicious of AIP.
Patients with IgG4-related diseases or suspicious of IgG4-related disease.
Patients with alcoholic pancreatitis.
Patients with idiopathic pancreatitis.
Patients with biliary stone-related pancreatitis.
Patients with Sjogren&#39;s syndrome.
Patients with interstitial nephritis.
Patients with interstitial pneuminia.
Patients with primary sclerosing cholangitis.
Patients who needs differential diagnosis to IgG4 related diseases.

Key exclusion criteria

Patients without the agreement to join this study.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Chiba tsutomu

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

54 Shogoinkawatamatch, Sakyo-ku, Kyoto,Japan

TEL

075-751-4319

Email

kodamayu@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kodama Yuzo

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

54 Shogoinkawatamatch, Sakyo-ku, Kyoto,Japan

TEL

075-751-4319

Homepage URL


Email

kodamayu@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Department of Gastroenterology and Hepatology,Kyoto University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Intractable Diseases, the Health and Labor Sciences Research Grants from Minister of Labor and Welfare of Japan.

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Center for Genomic Medicine, Kyoto University

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関西医科大学 (大阪府)
信州大学病院(長野県)
都立駒込病院(東京都)
鹿児島大学病院(鹿児島県)
慶應義塾大学病院(東京都)
京都大学病院(京都府)
金沢医科大学(石川県)
東北大学病院(宮城県)
九州大学病院(福岡県)
国立病院機構京都医療センター(京都府)
倉敷中央病院(岡山県)
名古屋大学病院(愛知県)
名古屋市立大学病院(愛知県)
東京大学病院(東京都)
昭和大学病院
藤田保険衛生大学坂文種報德會病院(愛知県)
愛知がんセンター中央病院(愛知県)


Other administrative information

Date of disclosure of the study information

2010 Year 04 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2010 Year 02 Month 02 Day

Date of IRB


Anticipated trial start date

2010 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 04 Month 22 Day

Last modified on

2016 Year 04 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003782


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name